EFFECTS OF IBANDRONATE FOR THE MANAGEMENT OF POSTMENOPAUSAL OSTEOPOROSIS

被引：0
|
作者：
Arsenovic, Branka M. [1 ]
Vuksanovic, Miljanka M. [1 ]
Beljic-Zivkovic, Teodora [1 ]
Lazarevic, Maja M. [2 ]
Arsenovic, Srdjan M. [3 ]
Djurica, Snezana [4 ]
机构：
[1] Zvezdara Univ, Div Endocrinol Diabet & Metab, Med Ctr, Dept Osteoporosis, Belgrade, Serbia
[2] St Charles Hosp, Dept Psychiat, London W10 6DZ, England
[3] Univ Hosp Dr Dragisa Misovic, Dept Radiol, Belgrade, Serbia
[4] Univ Belgrade, Fac Med, Sch Med, Dept Endocrinol, Belgrade, Serbia
来源：
OSTEOPOROSIS INTERNATIONAL | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S193 / S194
页数：2
相关论文
共 50 条
  • [1] Ibandronate in the Management of Postmenopausal Osteoporosis
    Reginster, Jean-Yves
    Hiligsmann, Mickael
    Rabenda, Veronique
    Zegels, Brigitte
    Neuprez, Audrey
    Bruyere, Olivier
    [J]. CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1409 - 1421
  • [2] Ibandronate: A potent new bisphosphonate in the management of postmenopausal osteoporosis
    Papapoulos, SE
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2003, 57 (05) : 417 - 422
  • [3] Ibandronate A Review of its Use in the Management of Postmenopausal Osteoporosis
    Frampton, James E.
    Perry, Caroline M.
    [J]. DRUGS, 2008, 68 (18) : 2683 - 2707
  • [4] Ibandronate and prevention of postmenopausal osteoporosis
    Maravic, M
    Landais, P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (05) : 608 - 609
  • [5] Oral and intravenous ibandronate in the management of postmenopausal osteoporosis: A comprehensive review
    Reginster, JY
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (28) : 3711 - 3728
  • [6] Systematic review of ibandronate for postmenopausal osteoporosis
    Schnitzer, TJ
    Stephenson, JJ
    Chen, YT
    Sen, SS
    Long, S
    Abbott, T
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A135 - A135
  • [7] Quarterly intravenous ibandronate for postmenopausal osteoporosis
    Emkey, Ronald D.
    [J]. WOMENS HEALTH, 2008, 4 (03) : 219 - 228
  • [8] Ibandronate and prevention of postmenopausal osteoporosis - Reply
    Stakkestad, JA
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (05) : 609 - 610
  • [9] Parenteral Ibandronate in the Therapy of postmenopausal Osteoporosis
    Broell, H.
    Dobnig, H.
    Resch, H.
    Erlacher, L.
    Fahrleitner-Pammer, A.
    Finkenstedt, G.
    Holzer, G.
    Pietschmann, P.
    Pirich, C.
    Wicker, A.
    [J]. JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 : 2 - 8
  • [10] Oral ibandronate in the management of postmenopausal osteoporosis: Review of upper gastrointestinal safety
    Epstein, S
    Delmas, PD
    Emkey, R
    Wilson, KM
    Hiltbrunner, V
    Schimmer, RC
    [J]. MATURITAS, 2006, 54 (01) : 1 - 10
12345